Table 2 Proportion of users with excessive use and the fraction of total consumption accounted for by excessive users by category of excessive use; > 365 DDD/year, > 730 DDD/year, > 1095 DDD/year, and by psychoactive drug category
> 365 DDD | > 730 DDD | > 1095 DDD | ||||
|---|---|---|---|---|---|---|
Proportion of users (%) | Proportion of consumption (%) | Proportion of users (%) | Proportion of consumption (%) | Proportion of users (%) | Proportion of consumption (%) | |
Carisoprodol | 1.9 | 26.4 | 0.4 | 9.8 | 0.1 | 5.4 |
Codeine | 2.5 | 29.9 | 0.5 | 10.2 | 0.1 | 4.5 |
Diazepam | 7.6 | 43.3 | 1.6 | 15.4 | 0.5 | 7.2 |
Oxazepam | 4.2 | 31.3 | 0.8 | 10.6 | 0.2 | 4.5 |
Nitrazepam | 19.9 | 53.9 | 3.3 | 16.7 | 1.1 | 8.1 |
Flunitrazepam | 24.9 | 62.0 | 6.1 | 27.9 | 2.2 | 14.9 |
Zopiclone | 12.6 | 42.0 | 1.4 | 9.7 | 0.4 | 4.3 |
Zolpidem | 8.5 | 41.3 | 1.3 | 12.6 | 0.4 | 6.5 |
Anxiolytics (including alprazolam) | 7.4 | 47.4 | 2.1 | 23.9 | 0.9 | 15.8 |
Hypnotics (including clomethiazole) | 15.1 | 47.6 | 2.1 | 13.2 | 0.7 | 6.5 |
All studied drugs | 11.6 | 58.7 | 3.4 | 30.8 | 1.6 | 19.6 |